Carbon nanotechnology has emerged as a transformative force in the pharmaceutical field, offering innovative solutions for drug delivery, diagnostics, and therapeutics. Engineered carbon-based nanomaterials, such as carbon nanotubes and graphene, exhibit unique properties that make them ideal candidates for various biomedical applications. These nanomaterials provide a high surface area and tunable surface chemistry, enabling precise control over drug loading and release kinetics.
In drug delivery, carbon nanocarriers can enhance the solubility and stability of poorly water-soluble drugs, improving their bioavailability. Additionally, the exceptional conductivity of carbon nanotubes has facilitated the development of biosensors for sensitive and rapid detection of biomolecules, aiding in early disease diagnosis. Moreover, carbon nanomaterials possess excellent biocompatibility and can be functionalized to target specific tissues or cells, minimizing off-target effects. Despite the promising potential, challenges such as biodegradability and long-term toxicity need to be addressed to ensure the safe and effective integration of carbon nanotechnology into pharmaceutical applications. Ongoing research in this burgeoning field holds the promise of revolutionizing drug development and patient care, ushering in a new era of precision medicine.
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Vladlen Slepak
University of Miami Miller School of Medicine, United States
Andreas M Papas
Antares Health Products, United States
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian FederationSubmit your abstract Today
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Emerging formulation and delivery applications of Vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia